Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumors.
Eduardo MoreoSantiago UrangaAna PicóAna Belén GómezDenise Nardelli-HaefligerCarlos Del Fresno SánchezIngrid MurilloEugenia PuentesEsteban RodríguezMar Vales-GómezJulian PardoDavid SanchoCarlos MartinNacho AguilóPublished in: Journal for immunotherapy of cancer (2022)
These results contribute to the understanding of the mechanisms behind successful bacterial immunotherapy against BC and characterize a novel therapeutic approach for BCG-unresponsive NMIBC cases.